HomeKROS • NASDAQ
add
Keros Therapeutics Inc
Previous close
$11.02
Day range
$10.87 - $11.23
Year range
$9.12 - $22.55
Market cap
217.48M USD
Avg Volume
391.02K
P/E ratio
4.80
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 385.00K | -87.34% |
Operating expense | 11.74M | 10.11% |
Net income | -23.46M | 49.03% |
Net profit margin | -6.09K | -302.76% |
Earnings per share | -0.86 | 24.56% |
EBITDA | -28.77M | 45.64% |
Effective tax rate | 6.06% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 287.42M | -48.67% |
Total assets | 338.02M | -45.12% |
Total liabilities | 34.89M | -21.30% |
Total equity | 303.13M | — |
Shares outstanding | 19.72M | — |
Price to book | 0.71 | — |
Return on assets | -13.49% | — |
Return on capital | -14.01% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -23.46M | 49.03% |
Cash from operations | -27.29M | 40.68% |
Cash from investing | -134.00K | 53.63% |
Cash from financing | -378.63M | -601.21% |
Net change in cash | -406.06M | -1,488.37% |
Free cash flow | -16.61M | 50.14% |
About
Founded
2015
Headquarters
Website
Employees
78
